Myriamed GmbH

22/12/2025

🎄 As the year slowly comes to a end and christmas is near, we want to say thank you!

2025 has been a year of meaningful collaboration, trust, and shared commitment.

We at myriamed GmbH would like to thank our partners, clients, and the many healthcare and biotech professionals who have worked with myriamed and continue to place their confidence in us.

At myriamed GmbH, we are proud to support the acceleration of drug development through our proprietary human cell and engineered tissue models — helping to define safe and effective drug effects early in the process and moving promising therapies closer to clinical reality.

Our unique platforms, including advanced engineered heart and skeletal muscle tissues, are designed to reduce risk, refine discovery, and enable more predictive, human-relevant insights for our partners in the pharmaceutical and biotech industry.

As we celebrate this festive season, we reflect on the breakthroughs, partnerships, and shared goals that made this year special. 🩺✨

We wish you, your teams and families a joyful Christmas season, restful holidays, and continued success and good health 🎁🤍

We are looking forward to continuing our journey together in the year ahead!

The myriamed team !

11/12/2025

https://bsgn.esa.int/2025/12/09/innovate-beyond-earth-meet-the-second-cohort-of-esas-life-science-accelerator/

Following the 2nd Call of the BSGN Life Science Industry Accelerator, two groundbreaking projects have been selected for acceleration and deployment in orbit: PRICILIA and MyrSpaceCardio.

26/09/2025

🚀 You know that moment when your cell culture experiments finally just work? That’s exactly what the myriamed GmbH myrPlates are built for.

These cell culture plates from myriamed GmbH make it simple to set up reproducible, gradient-based assays—no endless tinkering, just reliable results.

And the best part? You can order them anytime in the myriamed Biotech Online Shop: https://lnkd.in/eKgEhEYZ. Or just give us a message for your individual quote.

✅ Besides the gradient version, you can also get myrPlate-Uniform plates, where all stretchers in each plate have the same stiffness.

✅ You choose among six stiffness levels (TM4 med through TM9 med) depending on your tissue model.

Meanwhile, the myrPlate Gradient version contains one row of stretchers that each have those same stiffness levels (TM4 → TM9) in a single plate, giving you a built-in stiffness sweep.

Each 48-well plate uses stretchers with a fluorescent dye, so you can track mechanical forces optically.

They also fit perfect in the myrImager, we made together with SYNENTEC ! Learn more: https://lnkd.in/dEsQxzUw

Give your next experiment the smooth start it deserves — and pick the variant that fits your model best.

Need more Information? Just get in contact with the myriamed GmbH Team via www.myriamed.com.

myriamed's proprietary human cell and engineered tissue models can assist drug developers in defining safe and effective doses for first in human studies. Our platform technologies find broad applications in early stages of drug discovery and refinement of the most promising therapeutic candidates.

21/09/2025

Need better, faster preclinical results?

Today’s scientists face intense pressure to shorten timelines and improve accuracy in new drug development. One of the most powerful ways to achieve both is by leveraging human cell and tissue models, which are rapidly transforming the preclinical landscape.

From early lead discovery to advanced individualized phenotypic screens, these models enable more predictive data, helping you identify promising therapeutic candidates sooner and reduce costly late-stage failures.

myriamed’s myrServices offers:
• A broad portfolio of highly standardized assays for consistent, reproducible results
• Custom-made solutions tailored to your specific research questions
• Expertise to guide projects from concept through to actionable insights

By partnering with myriamed, you gain a trusted ally to accelerate drug development, enhance confidence in your findings, and move breakthrough therapies toward the clinic with greater speed.

🔬 Let’s talk about how myrServices can advance your next discovery.

21/06/2025

06/06/2025

https://www.linkedin.com/posts/myriamed-gmbh_caat-youtube-3rs-activity-7335894106302263296-43Eo?utm_source=share&utm_medium=member_ios&rcm=ACoAABD2-dMBRZ1bS8Sui8pnUxFoWN1fXkUKgOM

🔬 Rethinking Research: How myriamed GmbH Organoids Can Reduce Animal Testing 🧫 At myriamed GmbH we’re committed to driving innovation and ethics in biomedical research. Our advanced human organoids—miniaturized, functional 3D models of human organs—are changing the way we study disease a...

14/04/2025

🚫🐁 Goodbye Animal Testing? The Future Is Human (Cells)!

📢 Big news: The FDA is phasing out its animal testing requirement for drug development. Instead, it's embracing human-based models, AI, and organoids — a major win for science and ethics.

vegconomist - das vegane Wirtschaftsmagazin shared the news in this

🔗 article: https://www.linkedin.com/posts/vegconomist_fda-to-phase-out-animal-testing-requirement-activity-7317521002047971329-gHWY?utm_source=share&utm_medium=member_ios&rcm=ACoAABD2-dMBRZ1bS8Sui8pnUxFoWN1fXkUKgOM

The myriamed GmbH team is also excited about this news !👩‍🔬🧪

Because at myriamed GmbH, we're proud to be part of this transformation. Our cutting-edge 3D organoid technology is reducing the need for animal testing by bringing drug testing closer to the real thing — the human body.

🔬 What makes our organoids special?

We create miniaturized, functional human heart and skeletal muscle tissues from stem cells (iPSCs).

These organoids:

✅ Mimic real human responses better than animal models

✅ Allow high-throughput, human-relevant screening

✅ Are ethically aligned and cost-effective

✅ Speed up the discovery of safer, more effective drugs

🌍 Why it matters

Animal testing isn’t just an ethical challenge — it’s a scientific one. Animals often react differently to drugs than humans do. That means wasted time, resources, and even missed opportunities.

💡 By replacing animal models with human-based 3D tissues, we're not just making science more compassionate — we're making it more accurate. 🧠❤️

🙌 We’re excited to see regulatory bodies like the FDA support alternatives like ours. The future of drug development is here — and it’s powered by organoids.

Want to learn more? Just get in contact !

The FDA is phasing out animal testing for monoclonal antibody therapies and other drugs, replacing it with AI-based models, human cell lines, and real-world safety data to improve drug safety, reduce costs, and accelerate the evaluation process. https://lnkd.in/g9vVPSeq

07/04/2025

https://www.linkedin.com/posts/myriamed-gmbh_cardiac-skeletal-neuro-activity-7314954863669403648-jC4v?utm_source=share&utm_medium=member_ios&rcm=ACoAABD2-dMBRZ1bS8Sui8pnUxFoWN1fXkUKgOM

Meet Dr. Brian Golat from myriamed GmbH this week in Heidelberg !

25/03/2025

https://www.linkedin.com/posts/myriamed-gmbh_myriamed-gmbh-revolutionizing-3d-tissue-activity-7305507417306337280-ceF2?utm_source=share&utm_medium=member_ios&rcm=ACoAABD2-dMBRZ1bS8Sui8pnUxFoWN1fXkUKgOM

🔬 myriamed GmbH: Revolutionizing 3D Tissue Engineering with MyrPlates! myriamed GmbH is a pioneering company in the field of engineered tissues, dedicated to providing advanced solutions for biomedical research and drug development. With over 20 years of experience, Myriamed focuses on heart and ...

07/03/2025

https://www.linkedin.com/posts/myriamed-gmbh_the-myriamed-myrimager-activity-7302958874377031684-5xow?utm_source=share&utm_medium=member_android&rcm=ACoAABD2-dMBRZ1bS8Sui8pnUxFoWN1fXkUKgOM

🚀 Revolutionizing Drug Discovery: How the myrImager Unleashes the Power of 3D Tissue Analysis ! 🔬The myrImager is a high-throughput, video-optical imaging platform co-developed by myriamed GmbH and SYNENTEC GmbH. 📊 Designed to work seamlessly with myriamed's proprietary 48-well 3D cell/...

07/02/2025

https://www.instagram.com/p/DFfe4jyRtI9/?igsh=MWxzaHh3M3J1dTA2aw==

01/02/2025

https://www.n-tv.de/mediathek/videos/panorama/Wie-ein-Pflaster-erkrankte-Herzen-unterstuetzt-article25530549.html https://www.n-tv.de/mediathek/videos/panorama/Wie-ein-Pflaster-erkrankte-Herzen-unterstuetzt-article25530549.html

Ein Projekt der Universitätsmedizin Göttingen könnte bald für Hoffnung bei schwächeren Herzerkrankungen sorgen. Ein aus Stammzellen hergestelltes Pflaster soll dem Herz beim Schlagen helfen. Eine erste Studienphase läuft vielversprechend.